Syra Health Corp.

SYRA Healthcare Medical Care Facilities

Syra Health Corp.’s revenue for fiscal 2025 (year ended December 2025) was $7.2 million, down 9.47% from fiscal 2024.

Revenue
+51.5%
EPS
+221.5%
Free cash flow
+235.8%

Quarter to September 2026, against a year earlier

0.80 0.07 −8.05%
Market cap
$1.1M
P/E
14.7×
Fwd P/E
—
Dividend yield
—
F-score
5/9
Altman Z
−1.58
Beneish M
−3.54
Dividend safety
n/a

Syra Health Corp. (SYRA) P/E ratio

Alert me on P/E ratio

As of 6 November 2026, Syra Health Corp. (SYRA) trades at a P/E ratio of 14.7×. Over the past ten years it has ranged from 0.0× (June 2026) to 105× (July 2026); the current reading is higher than 88% of that period. That is below the Medical Care Facilities industry median of 18.7× and below the Healthcare sector median of 24.5×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —

Quarterly newest first

Period P/E ratio Change
Sep 2026 16.2× (74.68%)
Jun 2026 64.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
12 more quarters

Against its own ten years

Low 0.0× High 105×
Ten-year median 0.0×
Current reading's percentile 88

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on SYRA